• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房分离出的革兰氏阴性杆菌对超广谱β-内酰胺类抗生素和环丙沙星敏感性的比较。

Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units.

作者信息

Liu P Y, Lau Y J, Hu B S, Shyr J M, Shi Z Y, Tsai W S, Lin Y H, Tseng C Y

机构信息

Section of Infectious Diseases, Taichung Veterans General Hospital, Taiwan, ROC.

出版信息

Diagn Microbiol Infect Dis. 1995 Jul;22(3):285-91. doi: 10.1016/0732-8893(95)00096-s.

DOI:10.1016/0732-8893(95)00096-s
PMID:8565418
Abstract

The in vitro activities of extended-spectrum beta-lactam antibiotics (including piperacillin, cefotaxime, ceftriaxone, ceftazidime, cefepime, imipenem, and meropenems) were assessed and compared with the activity of ciprofloxacin against 366 clinical Gram-negative bacilli isolates from the intensive care units of Taichung Veterans General Hospital. The most prevalent species isolated were Pseudomonas aeruginosa and Acinetobacter baumannii. The activities of ceftazidime, cefepime, imipenem, and meropenem against these isolates were comparable to that of ciprofloxacin. Meropenem was found to be the most potent extended-spectrum beta-lactam antibiotic tested and the MIC50s and MIC90s for most of these multiresistant strains were lower than those of imipenem, ceftazidime, and cefepime, except for Stenotrophomonas maltophilia. The extended-spectrum beta-lactam antibiotics that were still active against S. maltophilia were piperacillin and ceftazidime. More than 50% of Enterobacter spp. were resistant to third-generation cephalosporins and piperacillin, but they remained susceptible to carbapenems and cefepime.

摘要

对广谱β-内酰胺类抗生素(包括哌拉西林、头孢噻肟、头孢曲松、头孢他啶、头孢吡肟、亚胺培南和美罗培南)的体外活性进行了评估,并与环丙沙星对台中荣民总医院重症监护病房分离出的366株临床革兰氏阴性杆菌的活性进行了比较。分离出的最常见菌种是铜绿假单胞菌和鲍曼不动杆菌。头孢他啶、头孢吡肟、亚胺培南和美罗培南对这些分离株的活性与环丙沙星相当。美罗培南被发现是所测试的最有效的广谱β-内酰胺类抗生素,除嗜麦芽窄食单胞菌外,大多数多重耐药菌株的MIC50和MIC90均低于亚胺培南、头孢他啶和头孢吡肟。对嗜麦芽窄食单胞菌仍有活性的广谱β-内酰胺类抗生素是哌拉西林和头孢他啶。超过50%的肠杆菌属对第三代头孢菌素和哌拉西林耐药,但它们对碳青霉烯类和头孢吡肟仍敏感。

相似文献

1
Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units.重症监护病房分离出的革兰氏阴性杆菌对超广谱β-内酰胺类抗生素和环丙沙星敏感性的比较。
Diagn Microbiol Infect Dis. 1995 Jul;22(3):285-91. doi: 10.1016/0732-8893(95)00096-s.
2
[Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].[中国重症监护病房医院革兰阴性杆菌耐药性的持续监测]
Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):375-81.
3
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.1991年至2003年台湾某大学医院引起医院感染的革兰氏阴性菌中抗菌药物使用与抗菌药物耐药性之间的关系。
Int J Antimicrob Agents. 2005 Dec;26(6):463-72. doi: 10.1016/j.ijantimicag.2005.08.016. Epub 2005 Nov 8.
4
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.八种广谱β-内酰胺类药物的抗菌活性及谱研究:1997年在美国102个医疗中心进行的一项监测试验。头孢吡肟研究组。
Diagn Microbiol Infect Dis. 1998 Mar;30(3):215-28. doi: 10.1016/s0732-8893(97)00234-4.
5
[Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].[1994年至2001年中国重症监护病房分离的非发酵革兰阴性杆菌的耐药性变化]
Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):385-90.
6
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.头孢地尔:一种具有抗碳青霉烯类和多药耐药革兰氏阴性杆菌活性的铁载体头孢菌素。
Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2.
7
Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.对六种广谱β-内酰胺抗菌药物针对来自日本22个医疗中心的2000多株临床分离菌的体外活性进行评估。日本抗菌药物耐药性研究组。
Diagn Microbiol Infect Dis. 1999 Jun;34(2):123-34. doi: 10.1016/s0732-8893(99)00019-x.
8
[Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].[医院革兰氏阴性病原菌的抗菌药敏模式:哈杰泰佩大学成人医院MYSTIC研究结果(2000 - 2004年)]
Mikrobiyol Bul. 2006 Jul;40(3):147-54.
9
In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.新型广谱β-内酰胺类抗生素对肠杆菌科细菌和非发酵菌的体外活性:来自奥地利重症监护病房的报告。奥地利碳青霉烯敏感性监测组
Wien Klin Wochenschr. 1999 Jul 30;111(14):549-54.
10
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.头孢匹罗与其他四种β-内酰胺类药物对血液学/肿瘤学及重症监护病房分离菌株的交叉敏感性。国际研究小组。
Scand J Infect Dis Suppl. 1993;91:25-32.

引用本文的文献

1
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.鲍曼不动杆菌对碳青霉烯类耐药的地理分布及时间趋势:一项综合荟萃分析。
PLoS One. 2024 Dec 16;19(12):e0311124. doi: 10.1371/journal.pone.0311124. eCollection 2024.
2
Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.全球临床分离嗜麦芽寡养单胞菌耐药率的地图绘制:系统评价和荟萃分析。
Ann Clin Microbiol Antimicrob. 2024 Mar 19;23(1):26. doi: 10.1186/s12941-024-00685-4.
3
Global prevalence and antibiotic resistance in clinical isolates of : a systematic review and meta-analysis.
全球临床分离株中的患病率及抗生素耐药性:一项系统评价和荟萃分析。
Front Med (Lausanne). 2023 May 5;10:1163439. doi: 10.3389/fmed.2023.1163439. eCollection 2023.
4
Acinetobacter Baumannii Phages: Past, Present and Future.鲍曼不动杆菌噬菌体:过去、现在和未来。
Viruses. 2023 Mar 3;15(3):673. doi: 10.3390/v15030673.
5
Current status of antimicrobial resistance in Taiwan.台湾地区抗菌药物耐药性的现状
Emerg Infect Dis. 2002 Feb;8(2):132-7. doi: 10.3201/eid0802.010244.
6
Meropenem: a review of its use in patients in intensive care.美罗培南:对其在重症监护患者中应用的综述
Drugs. 2000 Mar;59(3):653-80. doi: 10.2165/00003495-200059030-00016.
7
In vitro activity of fleroxacin against multiresistant gram-negative bacilli isolated from patients with nosocomial infections.氟罗沙星对从医院感染患者中分离出的多重耐药革兰氏阴性杆菌的体外活性。
Intensive Care Med. 1998 Aug;24(8):839-44. doi: 10.1007/s001340050675.
8
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.嗜麦芽窄食单胞菌相关感染的微生物学及临床方面
Clin Microbiol Rev. 1998 Jan;11(1):57-80. doi: 10.1128/CMR.11.1.57.
9
In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.β-内酰胺-β-内酰胺酶抑制剂组合对嗜麦芽窄食单胞菌的体外活性:抑制活性检测方法、时间-杀菌曲线与杀菌活性之间的相关性
Antimicrob Agents Chemother. 1997 Dec;41(12):2612-5. doi: 10.1128/AAC.41.12.2612.